Insiders who reported open-market trades in the last 12 months at the companies Tia L. Bush files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Karen M. Anderson - $9.65M in CNTA purchases and sales in the last 12 months
Gregory M. Weinhoff - $2.65M in CNTA purchases and sales in the last 12 months
Iqbal J. Hussain - $1.17M in CNTA purchases and sales in the last 12 months
Tia L. Bush is a corporate insider, tracked as Chief Technology & Quality Ofc of Centessa Pharmaceuticals plc (CNTA). InsiderAlpha holds 9 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Tia L. Bush last file a Form 4?
The most recent primary Form 4 on record is dated 24 June 2026, one of 9 filings going back to 2024.
Has Tia L. Bush been buying or selling stock?
Recorded transactions: 0 open-market purchases and 7 open-market sales ($4.52M) across all tracked filings.
Tia L. Bush is Chief Technology & Quality Ofc of Centessa Pharmaceuticals plc (CNTA). 9 SEC Form 4 filings on record going back to 2024, most recently on 24 June 2026. Most recent open-market trade: sold $1.12M of CNTA on 18 November 2025. Lifetime open-market sales: $4.52M.
Recent transactions
18
The latest 18 SEC Form 4 transactions reported by Tia L. Bush.
InsiderAlpha's records for Tia L. Bush go back to 2024: 9 primary Form 4 filings, an average of 3.0 per year. 10 recorded transactions carry a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
